Houston, TX, United States of America

Radjendirane Venugopal

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Radjendirane Venugopal. Retrieved from https://idiyas.com/inventor/radjendirane-venugopal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Radjendirane Venugopal: Innovator in Pharmaceutical Chemistry

Introduction

Radjendirane Venugopal is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on caffeic acid derivatives.

Latest Patents

Venugopal holds a patent for "Caffeic acid derivatives and uses thereof." This patent outlines various caffeic acid derivatives and their potential applications, including pharmaceutical compositions aimed at treating cancer. His work in this area demonstrates a commitment to advancing medical science and improving treatment options for patients.

Career Highlights

Venugopal is affiliated with the University of Texas System, where he continues to engage in research and development. His career is marked by a focus on innovative solutions in the pharmaceutical sector, contributing to the advancement of therapeutic methods.

Collaborations

Throughout his career, Venugopal has collaborated with esteemed colleagues such as Waldemar Priebe and Stanislaw Skora. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Radjendirane Venugopal's work exemplifies the impact of innovation in pharmaceutical chemistry. His contributions, particularly in the development of caffeic acid derivatives, highlight the importance of research in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…